Compare JBL & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBL | BDX |
|---|---|---|
| Founded | 1966 | 1897 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.2B | 43.0B |
| IPO Year | 1999 | 1998 |
| Metric | JBL | BDX |
|---|---|---|
| Price | $310.35 | $184.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $272.33 | $186.00 |
| AVG Volume (30 Days) | 840.8K | ★ 1.6M |
| Earning Date | 06-16-2026 | 05-07-2026 |
| Dividend Yield | 0.10% | ★ 2.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 6.01 | 1.59 |
| Revenue | ★ $25,282,320,000.00 | $21,840,000,000.00 |
| Revenue This Year | $15.81 | N/A |
| Revenue Next Year | $9.76 | $3.02 |
| P/E Ratio | ★ $50.72 | $117.94 |
| Revenue Growth | ★ 14.42 | 8.24 |
| 52 Week Low | $189.60 | $140.11 |
| 52 Week High | $428.93 | $213.08 |
| Indicator | JBL | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 41.55 | 64.39 |
| Support Level | $292.11 | $141.69 |
| Resistance Level | $325.27 | $193.07 |
| Average True Range (ATR) | 11.74 | 3.89 |
| MACD | -2.79 | -1.08 |
| Stochastic Oscillator | 15.67 | 55.06 |
Jabil Inc. is a U.S based company providing engineering, manufacturing, and supply chain solutions. It provides comprehensive electronics design, production, and product management services to companies in various industries and end markets. It operates through three segments: Regulated Industries, serving automotive, healthcare, and renewables; Intelligent Infrastructure, focused on AI, cloud, data centers, and communications, driving the majority of revenue; and Connected Living and Digital Commerce, specializing in digitalization and automation, such as robotics and warehouse automation. The company operates in the U.S., Mexico, China, Malaysia, Singapore, and several other markets.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.